Toronto Dominion Bank Has $10.16 Million Stake in Varian Medical Systems, Inc. (NYSE:VAR)

Toronto Dominion Bank lifted its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 18.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 74,653 shares of the medical equipment provider’s stock after buying an additional 11,498 shares during the quarter. Toronto Dominion Bank owned about 0.08% of Varian Medical Systems worth $10,160,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC lifted its holdings in shares of Varian Medical Systems by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 1,259,504 shares of the medical equipment provider’s stock worth $142,479,000 after purchasing an additional 84,116 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Varian Medical Systems by 3.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 355,174 shares of the medical equipment provider’s stock worth $40,242,000 after purchasing an additional 12,271 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Varian Medical Systems by 1,791.9% in the 1st quarter. Victory Capital Management Inc. now owns 25,540 shares of the medical equipment provider’s stock worth $3,620,000 after purchasing an additional 24,190 shares in the last quarter. Nissay Asset Management Corp Japan ADV lifted its holdings in shares of Varian Medical Systems by 2.4% in the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 9,216 shares of the medical equipment provider’s stock worth $1,306,000 after purchasing an additional 217 shares in the last quarter. Finally, First Allied Advisory Services Inc. bought a new position in shares of Varian Medical Systems in the 1st quarter worth $227,000. 91.31% of the stock is owned by institutional investors.

A number of equities analysts recently issued reports on VAR shares. TheStreet cut Varian Medical Systems from a “b” rating to a “c+” rating in a report on Monday, August 5th. Robert W. Baird set a $158.00 target price on Varian Medical Systems and gave the stock a “buy” rating in a report on Friday, July 26th. ValuEngine cut Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, August 20th. Barrington Research reiterated a “buy” rating and issued a $142.00 target price on shares of Varian Medical Systems in a report on Thursday, July 25th. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $141.22.

In other news, insider Kolleen T. Kennedy sold 1,242 shares of Varian Medical Systems stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of $137.99, for a total transaction of $171,383.58. Following the sale, the insider now directly owns 27,633 shares in the company, valued at approximately $3,813,077.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy E. Guertin sold 12,651 shares of Varian Medical Systems stock in a transaction on Monday, July 15th. The stock was sold at an average price of $135.21, for a total value of $1,710,541.71. Following the sale, the director now owns 13,589 shares in the company, valued at $1,837,368.69. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 72,063 shares of company stock worth $9,586,118. Company insiders own 0.78% of the company’s stock.

NYSE:VAR traded down $2.16 during trading hours on Friday, hitting $117.39. 1,146,688 shares of the company traded hands, compared to its average volume of 740,902. The firm’s 50-day simple moving average is $111.21 and its 200-day simple moving average is $128.77. Varian Medical Systems, Inc. has a one year low of $101.42 and a one year high of $142.50. The company has a market cap of $10.89 billion, a PE ratio of 26.05, a PEG ratio of 3.23 and a beta of 0.87.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.14 by $0.18. Varian Medical Systems had a return on equity of 24.91% and a net margin of 10.75%. The business had revenue of $825.80 million for the quarter, compared to analysts’ expectations of $762.29 million. During the same period last year, the business earned $1.04 EPS. The business’s revenue was up 16.5% on a year-over-year basis. On average, analysts forecast that Varian Medical Systems, Inc. will post 4.62 earnings per share for the current fiscal year.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Featured Article: What is Green Investing?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.